NancyDLeslieMD
Medical Genetics • Cincinnati, OHClinical Biochemical Genetics, Clinical Genetics
Professor, Pediatrics, University of Cincinnati College of Medicine
Dr. Leslie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Ml 4006
Cincinnati, OH 45229Phone+1 513-636-4760Fax+1 513-636-7297
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Medical Genetics and Genomics, 1993 - 1996- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Endocrinology, 1982 - 1989
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1982
Washington University in St. Louis School of MedicineClass of 1979
Certifications & Licensure
OH State Medical License 1983 - 2026- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
Publications & Presentations
PubMed
- 576 citationsEvidence-based path to newborn screening for Duchenne muscular dystrophy.Jerry R. Mendell, Chris Shilling, Nancy D. Leslie, Kevin M. Flanigan, Roula al-Dahhak
Annals of Neurology. 2012-03-01 - 218 citationsEarly Treatment with Alglucosidase Alfa Prolongs Long Term Survival of Infants with Pompe DiseasePriya S. Kishnani, Deya Corzo, Nancy D. Leslie, Daniel Gruskin, Ans T. van der Ploeg
Pediatric Research. 2009-09-01 - 214 citationsClinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseMarc Nicolino, Barry J. Byrne, James E. Wraith, Nancy D. Leslie, Hanna Mandel
Genetics in Medicine. 2009-03-01
Grant Support
- Rhgaa Treatment In Patients Over 6 And LESS THAN 36 Months OldNational Center For Research Resources2005–2007
- Iduronate-2-Sulfatase Replacement Therapy In MPS IINational Center For Research Resources2004–2007
- Rhgaa Treatment In Patients <6 Months OldNational Center For Research Resources2005–2006
- Rhgaa Treatment In Patients Over 6 &Less THAN 36 MonthsNational Center For Research Resources2004
- Genetic Models For GalactosemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1998
- Genetic Models For GalactosemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Ontogeny Of Glucagon Action: Monoclonal Antibody StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
